M, trading at $0.31 on the NASDAQ. This SniperIQ fundamentals page covers Trinity Biotech's valuation, profitability (net margin -85.3%), revenue ($44M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
M
Net Margin-85.3%
Revenue (FY25)$44M

Full research coverage

Frequently Asked Questions

What is Trinity Biotech's market cap?

Trinity Biotech (TRIB) has a market capitalization of approximately

M, trading at $0.31 on the NASDAQ. Market cap moves with the live share price.

How profitable is Trinity Biotech?

Trinity Biotech runs a net profit margin of -85.3%, a gross margin of 35.4%, and an operating margin of -25.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Trinity Biotech generate?

Trinity Biotech reported revenue of $44M for fiscal year 2025, with net income of -

7M and earnings per share (EPS) of -2. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Trinity Biotech pay a dividend?

Trinity Biotech does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Trinity Biotech financially healthy?

Trinity Biotech carries a debt-to-equity ratio of -1.92x and a current ratio of 0.25x, with a market beta of 1.00. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Trinity Biotech a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Trinity Biotech (TRIB) the key facts are: market cap

M, revenue $44M, 52-week range 0.2822-3.44. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Trinity Biotech's full fundamentals live

Get Trinity Biotech's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.